Answers are grounded in this paper and cite their sources.
Cohort study reveals molecular lipid signatures for cardiovascular disease in population cohorts, indicating superior risk assessment over standard lipid tests.
This study applied mass spectrometry-based lipidomics profiling to population-based cohorts and identified molecular lipid signatures for cardiovascular disease. Molecular lipid species constitute promising new biomarkers that outperform the conventional biochemical measurements of lipid classes currently used in clinics.
No takes yet. Share an insight, caveat, or question.
Stegemann et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: